by Mac Slavo, SHTF Plan:
Big pharma companies like Moderna, Pfizer, and Novavax are preparing for the newest COVID “vaccine” rollout coming this fall. The United States Food and Drug Administration’s Covid strain selection for the next round of shots is a decisive win for the companies creating and pushing these injections on the public.
On Friday, the FDA advised the three aforementioned companies to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5, one of the most “immune-evasive” COVID variants to date, if you “trust the science” and those asserting said science. The XBB.1.5 strain accounted for nearly 40% of all Covid cases in the U.S. in early June, but that proportion is slowly declining, according to data from the Centers for Disease Control and Prevention.